‹³ˆõî•ñ
Ž–¼ ‘ºŽR@r•F
ƒtƒŠƒKƒi ƒ€ƒ‰ƒ„ƒ}@ƒgƒVƒqƒR
E–¼ ‹³Žö
ŠwˆÊ –òŠw”ŽŽm
Œ¤‹†Žº –òŒø–ò—ŠwŒ¤‹†Žº@iˆã–ò‘‡Œ¤‹†“@IC‚TŠKj
“d˜b”ԍ† 043-226-2874
ƒ[ƒ‹ƒAƒhƒŒƒX murayama-toshi—faculty.chiba-u.jp@i—‚Í‘SŠp•\‹Lj
’S“–u‹` –ò—Šw‚h
–ò—Šw‚h‚h
–ò—Šw‚h‚h‚h
–òŠw‘‡‰‰K
•ªŽq¶–½‰ÈŠw
–ò—ŠwŽÀK
ê–啪–ì –ò—Šw
Œ¤‹†ƒe[ƒ} ×–EŠÔC×–E“àƒVƒOƒiƒ‹‹@\‚̉𖾂Ƒn–ò‚Ö‚Ì“WŠJ
Žå‚ÈŒ¤‹†‹ÆÑ Makiyama T, Nakamura H, Nishida A, Murayama T.: C2-Di-ethyl-ceramide-1-phosphate as an inhibitor of group IVA cytosolic phospholipase A2. (2012) Eur. J. Pharmacol. 697, 144-151.

Kawashima T*, Yamazaki R*, Matsuzawa Y, Yamaura E, Takabatake M, Otake S, Ikawa Y, Nakamura H, Fujino H, Murayama T.: Contrary effects of sphingosine-1-phosphate on expression of ?-smooth muscle actin in transforming growth factor ?1-stimulated lung fibroblasts. (2012) Eur. J. Pharmacol. 696, 120-129. (* Equally contributed two top authors)

Nakamura H, Yasufuku K, Makiyama T, Matsumoto I, Fujino H, Murayama T.: Arachidonic acid metabolism via cytotoloc phospholipase A2? induces cytotoxicity in Niemann-Pick disease type C cells. (2012) J. Cell. Physiol. 227, 2847-2855.

Kato E, Yamane S, Nomura R, Matsumoto K, Tashima K, Horie S, Saito T, Fujino H, Murayama T.: Dysfunction of neurogenic VIP-induced relaxation in mouse distal colon with dextran sulfate sodium-induced colitis. (2012) Pharmacol. Res. 65, 204-212.
Š‘®Šw‰ï “ú–{–ò—Šw‰ï
“ú–{–òŠw‰ï
“ú–{¶‰»Šw‰ï
“ú–{_Œo‰»Šw‰ï
ŠwŠO‚Å‚Ì‹³ˆçEŒ¤‹†Šˆ“® @